An investor asked on the investor interaction platform: Hello, with Pfizer and other pharmaceutical companies producing drugs in large quantities to treat the epidemic, will there be a significant increase in the company’s performance if the global demand and price of carbonic anhydride rise together next year?
Aba Chemicals Corporation(300261) (300261. SZ) said on the investor interaction platform on December 29 that as of December 28, 2021, the sales revenue of the company’s carbonic anhydride and its derivatives was 27.073 million yuan, accounting for about 1% – 2% of the company’s total operating revenue in 2021, which is relatively small, and is not expected to have a significant impact on the company’s performance in 2021 and 2022. Please refer to the reply to the letter of concern of Shenzhen Stock Exchange disclosed by the company on December 28, 2021. Please pay attention to investment risks, make prudent decisions and invest rationally.
(Daily Economic News)
